Results 221 to 230 of about 139,988 (355)

The safety of proton pump inhibitors [PDF]

Alimentary Pharmacology & Therapeutics, 2001
openaire   +3 more sources

Antioxidant Carbon Dot of Selenomethionine Alleviates Oxidative Stress in Intervertebral Disc Degeneration

Advanced Science, EarlyView.
A selenomethionine‐derived carbon dot (Se‐Met‐CD) serves as a potent nano‐antioxidant, efficiently scavenging reactive oxygen species, protecting nucleus pulposus cells from oxidative damage, restoring extracellular matrix homeostasis, and significantly mitigating intervertebral disc degeneration in vivo, which demonstrates great promise as a nanozyme ...
Qingzheng Zhang, Zongtai Liu, Yirong Sun, Changfeng Fu, Jianxun Ding   +4 more
wiley   +1 more source

Interplay between dietary nitrate metabolism and proton pump inhibitors: impact on nitric oxide pathways and health outcomes. [PDF]

Front Nutr
Basaqr R, Babateen A.
europepmc   +1 more source

Effects of Proton Pump Inhibitors SCH 28080, SPI-447 and Rebeprazole on the Gastric Phospholipid Flippase Activity.

, 2000
Magotoshi Morii, Isao Wanajo, Hidehiro Suzuki, Takanari Murata, Noriaki Takeguchi   +4 more
openalex   +2 more sources

Electronic and Steric Tuning of Molecular Acidity toward Unified Models for Excited State Proton Transfer

Advanced Science, EarlyView.
Conventional excited‐state proton transfer (ESPT) theories explain the kinetics of fluorescent photoacids, but face challenges for weakly or nonfluorescent ones. This missing link is bridged by making and dissecting series of green fluorescent protein chromophore derivatives with varied photoacidities via strategic substitutions. Structure‐photoacidity
Cheng Chen, Ivan N. Myasnyanko, Mikhail S. Baranov, Chong Fang   +3 more
wiley   +1 more source

Vonoprazan and proton pump inhibitors: Which is superior for <i>Helicobacter pylori</i> eradication? [PDF]

World J Gastroenterol
Ozercan M, Tawheed A, Ismail A, Amer MS, El-Kassas M.   +4 more
europepmc   +1 more source

Factors affecting Helicobacter pylori eradication using a seven-day triple therapy with a proton pump inhibitor, tinidazole and clarithromycin, in brazilian patients with peptic ulcer [PDF]

, 2001
Fernando Marcuz Silva, Schlioma Zaterka, Jaime Natan Eisig, Ethel Zimberg Chehter, Décio Chinzon, Antônio Atílio Laudanna   +5 more
openalex   +1 more source

Toward Complete CO2 Electroconversion: Status, Challenges, and Perspectives

Advanced Energy Materials, EarlyView.
Electrocatalytic CO2 reduction and CO2 batteries face challenges in achieving complete CO2 conversion with high conversion rates and Faradaic efficiency simultaneously. Existing systems compromise one for the other with incomplete CO2 conversion and inefficiencies, hindering practical applications. This perspective highlights state‐of‐the‐art progress,
Changfan Xu, Ping Hong, Yulian Dong, Marc Robert, Guosheng Shao, Yong Lei   +5 more
wiley   +1 more source

Proton pump inhibitors are not associated with an increased risk of <i>Clostridioides difficile</i> infection: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Gut Microbes
Floria DE, Obeidat M, Váncsa S, Kávási SB, Földvári-Nagy L, Hegyi P, Veres DS, Drug VL, Erőss B.   +8 more
europepmc   +1 more source

Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD.

Journal of the American Society of Nephrology, 2016
Yan Xie, Benjamin Bowe, Tingting Li, H. Xian, S. Balasubramanian, Z. Al-Aly   +5 more
semanticscholar   +1 more source